SCRIPTALERT+ Trademark

Trademark Overview

On Wednesday, October 19, 2016, a trademark application was filed for SCRIPTALERT+ with the United States Patent and Trademark Office. The USPTO has given the SCRIPTALERT+ trademark a serial number of 87208144. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, January 30, 2025. This trademark is owned by Express Scripts, Inc.. The SCRIPTALERT+ trademark is filed in the Advertising, Business and Retail Services category with the following description:

Pharmacy benefit analysis services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits all to identify potential cost savings; drug utilization review services for pharmacy benefit management clients; pharmaceutical cost management services for pharmacy benefit management clients; strategic analysis, reporting and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior and healthcare use behavior, all to identify potential cost savings; safety management efforts, namely, tracking, monitoring, reporting, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, all to identify potential cost savings
scriptalert+

General Information

Serial Number87208144
Word MarkSCRIPTALERT+
Filing DateWednesday, October 19, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, January 30, 2025
Registration Number5558278
Registration DateTuesday, September 11, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2018

Trademark Statements

Pseudo MarkSCRIPT ALERT PLUS
Goods and ServicesPharmacy benefit analysis services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits all to identify potential cost savings; drug utilization review services for pharmacy benefit management clients; pharmaceutical cost management services for pharmacy benefit management clients; strategic analysis, reporting and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior and healthcare use behavior, all to identify potential cost savings; safety management efforts, namely, tracking, monitoring, reporting, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, all to identify potential cost savings

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, October 24, 2016
Primary Code035
First Use Anywhere DateWednesday, May 18, 2016
First Use In Commerce DateWednesday, May 18, 2016

Trademark Owner History

Party NameEXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressST. LOUIS, MO 63121
Party NameEXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressST. LOUIS, MO 63121
Party NameEXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressST. LOUIS, MO 63121
Party NameExpress Scripts, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63121

Trademark Events

Event DateEvent Description
Saturday, October 22, 2016NEW APPLICATION ENTERED
Monday, October 24, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 25, 2016NOTICE OF PSEUDO MARK E-MAILED
Monday, December 26, 2016ASSIGNED TO EXAMINER
Wednesday, December 28, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 28, 2016NON-FINAL ACTION E-MAILED
Wednesday, December 28, 2016NON-FINAL ACTION WRITTEN
Monday, June 26, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 26, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 5, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, July 21, 2017NON-FINAL ACTION WRITTEN
Friday, July 21, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 21, 2017NON-FINAL ACTION E-MAILED
Monday, January 22, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2018FINAL REFUSAL E-MAILED
Tuesday, January 23, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 12, 2018FINAL REFUSAL WRITTEN
Monday, February 12, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, May 18, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, May 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 26, 2018PUBLISHED FOR OPPOSITION
Monday, September 11, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 6, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 26, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 11, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, June 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 11, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, September 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 29, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 30, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 30, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, September 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

scriptalert management cost pharmacy benefit potential identify drug regarding healthcare services